If memory serves me correctly wasn't it KHA's engineer who provided the original, and maybe a second opinion--all consistently against striping and markers generally on our multi-modal paths prior to CD4 striping their paths? If so why would anyone ask and pay the same organization (engineer) for an opinion. Why would their position now be any different?
|